HAYWARD, Calif., May 4 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (Nasdaq: SLTM), a global leader in the medical aesthetics market, today announced that it will present to the investment community at the following upcoming investor conferences:

Stephen J. Fanning, Chairman, President and Chief Executive Officer, will review the company’s business strategy and recent corporate events at both conferences.

Attendance at these conferences is by invitation only. Solta will offer a live audio webcast of these presentations which may be accessed at the Investor Relations section of the Company’s website at www.solta.com. An archived replay for both will be available for 30 days following each event at www.solta.com.

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry’s three premier brands: Thermage®, Fraxel® and Isolaz®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

SOURCE Solta Medical, Inc.